Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 31Leukemia 20Lymphoma 19Breast Neoplasms 19Burkitt Lymphoma 15Lymphoma, Large B-Cell, Diffuse 9Leukemia, Myeloid, Acute 9Myelodysplastic Syndromes 8Central Nervous System Neoplasms 8Lymphoma, Non-Hodgkin 7Anemia, Refractory, with Excess of Blasts 7Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6Leukemia, Myelomonocytic, Chronic 6Hodgkin Disease 6Lymphoma, Follicular 5Leukemia, Lymphocytic, Chronic, B-Cell 5Leukemia, Biphenotypic, Acute 5Dendritic Cell Sarcoma, Interdigitating 5Acquired Immunodeficiency Syndrome 5Osteosarcoma 4Myeloproliferative Disorders 4Multiple Myeloma 4Lymphoma, Mantle-Cell 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, Large-Cell, Anaplastic 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Myeloid, Accelerated Phase 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4HIV Infections 4Congenital Abnormalities 4

Interventions

Temozolomide 4Bevacizumab 3Vorinostat 2Immunoglobulin G 2Disulfides 2veliparib 1romidepsin 1ispinesib 1cediranib 1Vincristine 1Prednisone 1Nivolumab 1Methotrexate 1Lomustine 1Lapatinib 1Irinotecan 1Ifosfamide 1Gelclair 1Fluorodeoxyglucose F18 1Etoposide 1Dexamethasone 1Clinical Laboratory Techniques 1Cisplatin 1Carboplatin 1Calcium Dobesilate 1CK0238273 12,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Spinal Cord Neoplasms × Methotrexate × Clear all
NCT00278278 2013-12-19

Combination Chemotherapy and Radiation Therapy With or Without Methotrexate in Treating Young Patients With Newly Diagnosed Gliomas

National Cancer Institute (NCI)

Phase 3 Unknown
150 enrolled
CNS

Astrocytoma, Spinal Cord Neoplasms, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡